2024-01 |
Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma |
Cancer Research and Treatment
|
2024-01 |
Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific |
Oral Oncology
|
2023-12 |
Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy |
Radiotherapy and Oncology
|
2023-10 |
Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and Chondrosarcomas |
Cancers
|
2023-06 |
Prognosis prediction for glioblastoma multiforme patients using machine learning approaches: Development of the clinically applicable model |
Radiotherapy and Oncology
|
2023-04 |
Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments |
Cancers
|
2023-02 |
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer |
International Journal of Radiation Oncology Biology Physics
|
2022-12 |
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer |
Radiation Oncology
|
2022-12 |
A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease |
International Journal of Radiation Oncology Biology Physics
|
2022-12 |
A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11) |
CLINICAL LUNG CANCER
|
2022-11 |
Association of Sinoatrial Node Radiation Dose With Atrial Fibrillation and Mortality in Patients With Lung Cancer |
JAMA oncology
|
2022-11 |
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600–mutant advanced melanoma |
Journal of the American Academy of Dermatology
|
2022-10 |
Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy |
Breast
|
2022-10 |
Role of Local Treatment for Oligometastasis: A Comparability Based Meta-Analysis |
Cancer Research and Treatment
|
2022-09 |
Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma |
Cancers
|
2022-08 |
Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study |
Journal of Neurosurgery
|
2022-06 |
Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
2022-03 |
Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study |
International Journal of Clinical Oncology
|
2022-01 |
Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 Mutations |
Cancer Research and Treatment
|
2022-01 |
Predicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy |
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
|
2022-01 |
A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|